Navigation Links
ISAR-REACT 3 Pits Bivalirudin vs. Unfractionated Heparin in PCI
Date:3/29/2008

Will direct thrombin inhibitor excel with high-dose clopidogrel on board?

CHICAGO, March 29 /PRNewswire/ -- A large randomized trial will shed light on the ideal combination of medications for preventing unwanted blood clotting during and shortly after percutaneous coronary intervention (PCI). Specifically, study investigators expect to determine whether bivalirudin, a direct inhibitor of the clotting protein thrombin, is better than unfractionated heparin, an indirect thrombin inhibitor, in patients who have also been treated with high-dose clopidogrel.

The Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment 3 (ISAR-REACT 3) study is being presented today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).

Bivalirudin has outperformed unfractionated heparin in some previous studies of PCI, but it's not clear how the two anti-clotting medications measure up when used in combination with what has become standard protocol in the cardiac catheterization laboratory: preloading with a 600-mg dose of clopidogrel, a medication that prevents clotting by inhibiting platelets.

"The distinguishing feature of our study is that a double-blind comparison of the two different anti-thrombotic regimens was performed against a backdrop of optimal oral anti-platelet loading therapy," said Adnan Kastrati, MD, a professor of cardiology and head of the catheterization laboratory at Deutsches Herzzentrum and Technical University, Munich, Germany. "We hypothesized that in patients who were optimally pre-treated with clopidogrel, bivalirudin would continue to prove superior to unfractionated heparin, at least
'/>"/>

SOURCE SCAI-ACCi2
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CHMP Recommends Expanded Use of Angiox(R) (Bivalirudin) in Europe for Patients With Acute Coronary Syndromes
2. Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting
3. Study Shows That Low-Molecular Weight Heparin (LMWH) was Associated with Reduced Hospital Costs of Venous Thromboembolism (VTE) Treatment Compared with Unfractionated Heparin (UFH)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... Fair Rate Funding, a lawsuit funding firm located ... dramatic increase in lawsuit filings in connection with the blood ... the Philadelphia Court of Common Pleas ... the Louisiana multi---district litigation (MDL), located ... Louisiana , the filings are also on ...
(Date:9/4/2015)... 2015  Essilor is pleased to announce the launch ... the eyestrain that comes with the constant connection to ... an everyday pair of glasses to provide comfort and ... smart phones, tablets and computers for hours at a ... a prescription but also those who currently wear contact ...
(Date:9/4/2015)... , September 4, 2015 ... by Application (Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Leukapheresis, and Photopheresis) by ... and by Product - Global Forecast to 2020", published ... reach USD 2.5 Billion by 2020, growing at a ... to 2020. Browse 139 Tables and ...
Breaking Medicine Technology:Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 2Xarelto Lawsuit Funding Firm, Fair Rate Funding Reports a Steady Rise in Xarelto Product Liability Lawsuit Filings 3Essilor Launches New Eyezen Glasses Specifically Designed For A Digital Focused Audience 2Apheresis Market Worth 2.5 Billion USD by 2020 2Apheresis Market Worth 2.5 Billion USD by 2020 3Apheresis Market Worth 2.5 Billion USD by 2020 4Apheresis Market Worth 2.5 Billion USD by 2020 5
... 2, 2011  MedinCell, a leading developer of low-cost, ... for key companion and food animal markets with ... Congress in Kansas City (December 6-8, 2011). ... over the duration of drug release, thereby making ...
... (NASDAQ: STXS ) today announced that executive ... be held on December 13-14, 2011 in New York. Michael ... is scheduled to present an overview of the Company ... A live webcast and subsequent archived ...
Cached Medicine Technology:MedinCell to Explore Controlled-Release Drug Delivery Partnerships at the World Animal Health Congress 2Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 2Stereotaxis to Present at the Oppenheimer Healthcare Conference on December 13, 2011 3
(Date:9/4/2015)... ... September 04, 2015 , ... On the ... effectively doubled the size of its annual health tech innovation program. Now featuring ... health startups to compete for cash and prizes to advance their technologies toward ...
(Date:9/4/2015)... ... September 04, 2015 , ... IVF New England, one of the largest ... "ManchVegas Happy Hour" in Manchester for women who wish to learn more about their ... Elm restaurant and lounge, 827 Elm Street, Manchester, NH from 6PM to 7PM , ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... three separate “Partner of the Year” awards at this year’s Microsoft Worldwide Partner ... Microsoft’s 2015 “Partner of the Year” Award Winner for Data Platform services, the ...
(Date:9/4/2015)... Pittsburgh, PA (PRWEB) , ... September 04, 2015 , ... Many consumers are looking for ... Cups could be their solution. , The patent-pending K Med Cups provide a quick and ... they help to relieve a cold, flu or cough. As a result, they enhance comfort ...
(Date:9/4/2015)... Washington (PRWEB) , ... September 04, 2015 , ... ... design and development of its first neighborhood created specifically for adults with intellectual, ... in the Phoenix Metro area and feature 30 cottage or “pocket” homes. In ...
Breaking Medicine News(10 mins):Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 2Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 3Health News:Scalability Experts is Awarded Three Separate 2015 “Partner of the Year” Awards at Microsoft’s Worldwide Partner Conference 4Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4
... who smoke are often the ones who make fewer ... happens in spite of the fact that smoking puts ... ,The finding holds true regardless of age, ... ,The study, reported in the latest American Journal ...
... guru Ravi Shankar's Art of Living methods for a ... in Russia. ,The Art of Living foundation and ... of understanding (MoU) for collaborative research and community healthcare ... visit to Krasnoyarsk from Monday. ,Under the agreement, ...
... the family at home can effectively encourager the ... for children suffering from diseases. ,Researchers from ... counseling could lead to healthier eating habits among ... // ,Genetic predisposition and unhealthy behaviors ...
... of middle-aged women and is characterized by recurring discomfort ... Symptoms vary and can include a combination of mild ... and pelvic area; and an urgent and/or frequent need ... become scarred or irritated, and pinpoint bleeding may appear ...
... a way to print DNA (Deoxyribonucleic Acid), which they ... as blood tests. ,The technique called Supramolecular Nano-Stamping ... not generally used in medical diagnostics.// ,The ... his colleagues at the Massachusetts Institute of Technology (MIT). ...
... University of Texas Medical Branch at Galveston (UTMB) have found ... cause the “mad cow disease” in people. According to their ... that are there in the blood causing the disease.// ... of Nature Medicine. The findings from the study are expected ...
Cached Medicine News:Health News:Marijuana-Derived Drug Promises Hope In Treating Bladder Infection 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: